SECTOR – HEALTHCARE
RATING – CORP*
MARKET CAP – £30m
CURRENT PRICE – 83p#
COMPANY DESCRIPTION
Venture Life Group plc is a consumer healthcare company. The group develops, manufactures, and commercialises self-care products which target the ageing population.
Patent Grants and Distribution Update
NORTHLAND VIEW
Venture Life announced that it was granted patents in Japan, Indonesia, Australia and Mexico for its UltraDEX Sensitive range.
The new patent grants add to the existing patents already granted for this product range in the USA, UK, South Africa and New Zealand. Patent applications are pending in many other jurisdictions, including the EU.
Venture Life also announced that it agreed with Boots Chemists (Boots) to list two new additional UltraDEX products in the UK, increasing the range of UltraDEX products stocked in store from eight to ten. Also, shelf space presence will further increase from July onwards.
Venture Life continues to extend its patent portfolio for its leading UltraDEX product range. Also, the listing of two additional UltraDEX products by Boots provides further validation of the range’s strength. Significant opportunities exist to continue expanding the range’s reach both domestically and internationally.
SECTOR – MINING
RATING – CORP*
MARKET CAP – £7m
CURRENT PRICE – 0.38p#
COMPANY DESCRIPTION
Keras Resources is an exploration company with interests in gold projects, located in Australia, a manganese project and a cobalt-nickel project, located in Togo.
From Yesterday: H117 results – Calidus to relist on the ASX in June
NORTHLAND VIEW
During H117 the company generated revenue of £0.9m but with a cost of sales of £1.0m, the Company made a gross loss of £0.1m from its operations at the Wycheproof open pit project.
LBT was up to £1.1m during H117 from £1.0m in H116
Net debt increased to £3.0m in H117 from £2.2m in H116.
Keras Resources’ current focus is ensuring the successful spin out of its Australian gold subsidiary onto the ASX through its RTO with Pharmanet Group. Pharmanet is expected to relist on the ASX in June as Calidus Resources. Once this transaction is completed Keras Resources will focus on its exposure to the potential market that may develop from advanced battery technology through its Togolese cobalt-nickel, and manganese projects.
Sunrise Resources (LON:SRES)
SECTOR – MINING
RATING – CORP*
MARKET CAP – £1.7m
CURRENT PRICE – 0.12p#
COMPANY DESCRIPTION
Sunrise Resources is an exploration company focused on its 100%-owned CS Pozzolan-Perlite Project, located in Nevada
From yesterday: H117 results – Refocusing on Pozzolan and Perlite
NORTHLAND VIEW
LBT increased to £0.16m in H117 from £0.15m in H116, despite a reduction in administrative expenses, largely due to impairments associated with a available for sale investment.
Net cash was up to £0.1m during H117 compared to £0.04m in H116.
Sunrise now plans to focus management and financial resources on development of CS Pozzolan and Perlite Project and other natural pozzolan opportunities.
The Company will seek progressive valorisation of its existing precious metal and other industrial mineral projects through joint venture, sale or other arrangements.
Following the completion of a concept study at the CS Project, Sunrise Resources refocused its activities from a wide ranging exploration portfolio in several jurisdictions to concentrating on the CS Pozzolan and Perlite Project, located in Nevada. The Company is also seeking to divest or reduce its financial exposure to its other assets and any funds that the Company raises will be focused on advancing its pozzolan and perlite project.